Filing Details
- Accession Number:
- 0001144204-18-007442
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-12 20:00:15
- Reporting Period:
- 2017-12-19
- Accepted Time:
- 2018-02-12 20:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042418 | Hedgepath Pharmaceuticals Inc. | HPPI | Services-Commercial Physical & Biological Research (8731) | 541641133 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611506 | Stefan Cross | Level 1, 99 King Street Melbourne, Vic C3 3000 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-19 | 600,000 | $162,660.00 | 0 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On December 19, 2017, Stefan Cross sold 600,000 shares of Common Stock to Mayne Pharma Ventures Pty Ltd.
Billionaire Hedge Funds
